Trial intelligence / Profile preview

Telmisartan for small abdominal aortic aneurysm

ACTRN12611000931976Phase 2Terminated

Sponsor
James Cook University
Start
Sep 2011
Modality
Small Molecules
Countries
3
01

Overview

Phase 2, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Telmisartan with Placebo (2 arms). Primary endpoint: Change in abdominal aortic aneurysm growth measured by maximum diameter on ultrasound. Started Sep 2011; status: terminated.

02

Drugs

telmisartan
03

Conditions

abdominal aortic aneurysm (AAA)

Beyond the preview

Go deeper on ACTRN12611000931976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000931976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call